2020
DOI: 10.1016/j.csbj.2020.07.021
|View full text |Cite
|
Sign up to set email alerts
|

A mutation can hide another one: Think Structural Variants!

Abstract: Next Generation Sequencing (NGS) using capture or amplicons strategies allows the detection of a large number of mutations increasing the rate of positive diagnosis for the patients. However, most of the detected mutations are Single Nucleotide Variants (SNVs) or small indels. Structural Variants (SVs) are often underdiagnosed in inherited genetic diseases, probably because few user-friendly tools are available for biologists or geneticists to identify them easily. We present here the diagnosis of two brothers… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 11 publications
(15 reference statements)
0
12
0
Order By: Relevance
“…In the GDAP1 gene genetic analyses detected the c.581C>G (p.Ser194*) mutation, homozygous in the patient and his affected brother, and heterozygous in the other family members. No other mutation in CMT-and peripheral neuropathies-associated genes was detected by targeted Next Generation Sequencing (NGS) (see [34] for the detailed protocol). Two control subjects, without any clinical neurological signs, were enrolled in this study: Ctrl-1, a 24-year-old man, and Ctrl-2, a 28-year old woman.…”
Section: Subjectsmentioning
confidence: 99%
“…In the GDAP1 gene genetic analyses detected the c.581C>G (p.Ser194*) mutation, homozygous in the patient and his affected brother, and heterozygous in the other family members. No other mutation in CMT-and peripheral neuropathies-associated genes was detected by targeted Next Generation Sequencing (NGS) (see [34] for the detailed protocol). Two control subjects, without any clinical neurological signs, were enrolled in this study: Ctrl-1, a 24-year-old man, and Ctrl-2, a 28-year old woman.…”
Section: Subjectsmentioning
confidence: 99%
“…Thus, whether the truncation variant in SACS is linked to a typical clinical manifestation of ARSACS is an issue that requires further exploration. Even this de novo large deletion containing SACS was the second report in the world [24], the CNV in SACS were already reported in many populations including Belgian, French, Italian, Canadian, German and Chinese [24][25][26][27][28][29][30]. Thus, SV might not be extremely rare, and we suggested that tools for detecting SVs such as CNVs should be used routinely for NGS data analysis in order to increase the rate of positive diagnosis.…”
Section: Discussionmentioning
confidence: 88%
“…Second, large genomic rearrangements and trinucleotide expansions cannot be reliably detected from exome-capture data, even though there are some detecting CNVs tools developed and based on the readdepth of NGS data, such as Exome Depth used in this study, cannot easily detect inversion or translocation [41]. Third, it is also likely that some causal variants will outside the coding regions and adjacent splice sites [42].…”
Section: Discussionmentioning
confidence: 92%
“…NGS strategy was performed using a 93-gene custom panel designed for diagnosis of CMT and associated neuropathies (as described by Miressi et al [22] ). The amplified library was prepared with Ion-P1-HiQ-Template-OT2-200 kit (Ampliseq-Custom; Life Technologies), sequenced on Ion-Proton sequencer (Life-Technologies), and mapped to the human-reference-genome GHCh37.…”
Section: Methodsmentioning
confidence: 99%